Vimarsana
Biggest News Aggregation in the World

Failed Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Failed Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Failed Trials Today - Breaking & Trending Today

Silently Struggling: Discussing the Unseen Burdens of SD - Vimarsana News

Silently Struggling: Discussing the Unseen Burdens of SD

Experts discuss the profound impact of seborrheic dermatitis on a patients' well-being, examining the common misconceptions, diagnostic delays, and societal judgments that hinder effective management and necessitate enhanced clinical outreach and patient education.

Addressing Misdiagnoses, Ensuring Accurate Diagnosis to Inform Appropriate Prescribing and Treatment for Alzheimer Disease - Vimarsana News

Addressing Misdiagnoses, Ensuring Accurate Diagnosis to Inform Appropriate Prescribing and Treatment for Alzheimer Disease

Symptoms of dementia can be difficult to differentiate from typical age-related behavior changes and other common and potentially curable conditions.

Another Oxurion eye disease drug flunks phase 2, leaving biotech all-in on last prospect - Vimarsana News

Another Oxurion eye disease drug flunks phase 2, leaving biotech all-in on last prospect

Oxurion is left with one last shot at success.

AbbVie cuts Galapagos cystic fibrosis med years after $45M buy - Vimarsana News

AbbVie cuts Galapagos cystic fibrosis med years after $45M buy

AbbVie is cutting a cystic fibrosis medicine after an interim analysis revealed that the therapy did nothing when added to a triple-combo regimen.

Game over: Bristol Myers, Nektar end $3.6B immuno-oncology program after 2 more late-stage flops - Vimarsana News

Game over: Bristol Myers, Nektar end $3.6B immuno-oncology program after 2 more late-stage flops

Bristol Myers Squibb and Nektar have read the last rites to their huge, failed cancer collaboration.